Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT00144560
Eligibility Criteria:
Inclusion criteria
* Patients who are diagnosed with RA according to the 1987 American College of Rheumatology (ACR) classification criteria
* Patients who contracted RA at least 6 months prior
Exclusion criteria
* Patients with Class IV Steinbrocker functional impairment at enrollment.
* Patients who have been treated for the underlying disease with a biological agent, such as infliximab or etanercept and have been receiving treatment with leflunomide, within 12 weeks before initiation of treatment with the probe drug
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT00144560
Study Brief:
Protocol Section:
NCT00144560